EXL.AX - Elixinol Global Limited

ASX - ASX Delayed Price. Currency in AUD
1.1500
-0.0350 (-2.95%)
At close: 4:10PM AEDT
Stock chart is not supported by your current browser
Previous Close1.1850
Open1.2300
Bid1.1450 x 0
Ask1.1600 x 0
Day's Range1.1400 - 1.2450
52 Week Range0.5100 - 5.9300
Volume1,217,930
Avg. Volume1,003,229
Market Cap157.667M
Beta (5Y Monthly)-0.66
PE Ratio (TTM)N/A
EPS (TTM)-0.0900
Earnings DateAug 29, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.32
  • Is Elixinol Global (ASX:EXL) Using Debt Sensibly?
    Simply Wall St.

    Is Elixinol Global (ASX:EXL) Using Debt Sensibly?

    Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

  • GlobeNewswire

    Elixinol Acquires Global IP Rights for Microencapsulation Technology

    Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, is pleased to announce that it has acquired the intellectual property rights over microencapsulated technology developed by Bionova. This transaction will allow Elixinol to utilize the microencapsulated technology globally.

  • GlobeNewswire

    EXL Raises A$50 Million to Support U.S. Expansion

    Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, recently announced that its parent company Elixinol Global (EXL) has raised A$50 million through the issue of approximately 12.8 million shares at A$3.90 per share to institutional investors. Proceeds acquired will be used to further expand operations in Colorado, Elixinol’s U.S. headquarters. The rapid growth displayed here is set to amplify the company’s presence in the U.S. by increasing production facilities in Colorado by an additional ~23,000 square feet to more than double the company’s current production capacity.

  • GlobeNewswire

    Elixinol Issues a Statement Following the Public FDA Hearing in Washington, D.C. on Friday, May 31

    DENVER, June 03, 2019 -- Elixinol issued the following statement regarding the public FDA hearing in Washington, D.C. on Friday, May 31. “We support the FDA’s intentions, we.

  • A Look At The Intrinsic Value Of Elixinol Global Limited (ASX:EXL)
    Simply Wall St.

    A Look At The Intrinsic Value Of Elixinol Global Limited (ASX:EXL)

    How far off is Elixinol Global Limited (ASX:EXL) from its intrinsic value? Using the most recent financial data, we'll...

  • GlobeNewswire

    Elixinol Granted CBD Processor Research Partner Authorization by New York State

    Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that it has been officially granted a CBD Processor Research Partner Authorization by the New York State Department of Agriculture and Markets. The Department promotes New York agriculture and its high-quality and diverse products, fosters agricultural environmental stewardship, and safeguards the State’s food supply, land, and livestock to ensure the viability and growth of New York’s agriculture industries.

  • GlobeNewswire

    Elixinol Partners with Cambrian Alliance

    Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that they have partnered with Cambrian Alliance (CA), one of the largest buying groups for independent pharmacies in the United Kingdom. The partnership allows CA members to access Elixinol brand products, an exclusive launch offer package, point of sale material and staff training. “We are delighted to work in partnership with Elixinol, providing our members with access to a new range of products,” said Nathan Wiltshire, CEO of Cambrian Alliance.

  • GlobeNewswire

    Elixinol to Acquire 25 Percent Stake in US-Based CBD Pet Products Brand Pet Releaf

    Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that they have purchased a 25 percent stake in Altmeds LLC, maker of the pioneering and market leading Pet Releaf hemp-derived CBD pet line. Pet Releaf hemp-derived CBD topical, edibles and oils for pets currently sell in over 4,000 independent pet stores throughout the USA and multiple international markets. “Pet Releaf and Elixinol share the same values in sourcing and end-product superiority,” said Stephen Smith, President and Co-Founder of Pet Releaf.

  • GlobeNewswire

    Elixinol and KBMD Health Launch New Hemp CBD Extract

    Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, announces its latest product in partnership with Ken Brown, MD of KBMD Health, KBMD CBD Extract in Elixinol’s signature Natural and Cinnamint flavors. Created in partnership with Dr. Brown, an established physician specializing in gastroenterology, this full-spectrum product contains 900mg of CBD in a 1oz tincture, and is intended to help promote abdominal health and support relief from discomfort in those impacted by digestive issues. Passionate about bridging the gap between natural and medical science, Dr. Brown has been utilizing Elixinol hemp CBD extract for over two years in his own gastroenterology practice to support the digestive wellness of hundreds of patients.

  • GlobeNewswire

    Elixinol Receives U.S. Hemp Authority Certification

    Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that it has received U.S. Hemp Authority™ Certification. The prestigious certification has only been granted to a total of 14 companies to date, and grants Elixinol the ability to use the Certified Seal of the U.S. Hemp Authority on all hemp product packaging and marketing materials. The U.S. Hemp Authority Certification Program is the hemp industry’s initiative to provide high standards, best practices, and self-regulation, in an effort to give confidence to consumers and law enforcement that hemp products are safe and legal.

  • GlobeNewswire

    Elixinol Global Limited strengthens Board with the addition of consumer retail specialist as Non-Executive Director

    DENVER, April 12, 2019 -- Elixinol Global Limited (EXL or the Company) (ASX:EXL; OTCQX:ELLXF), a global company operating in the industrial hemp, dietary supplements and.

  • GlobeNewswire

    Streetwise Reports Examines Best-of-Breed Hemp/CBD Producers

    Charlotte's Web Holdings Inc. and Elixinol Global Ltd. are pioneers in hemp/CBD. Elixinol, the fastest over the second half of 2018, has new, cutting-edge products and a lower relative valuation. Charlotte's Web's Q4 sales rebounded after a hiccup in Q3 and had solid Q/Q sales growth of 21%.

  • GlobeNewswire

    Elixinol Launches Extra-Strength Hemp Balm with Double the CBD of Original Balm

    DENVER, March 18, 2019 -- Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, announces a new take on a.

  • GlobeNewswire

    Elixinol Launches Water-Soluble Flavored CBD Powder with Proprietary Full-Spectrum Blends

    Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, announces its latest product innovation, Create | Build | Dream (C | B | D), a full-spectrum water-soluble hemp CBD powder. “Our CBD powders are all-natural, taste great and mix well with beverages, no matter the time of day,” said Chris Husong, Elixinol’s Sales & Marketing Director.

  • GlobeNewswire

    Elixinol Global Limited FY2018 Results Strong Revenue Growth of 121% Supported by Robust Balance Sheet to Drive Future Growth

    SYDNEY, Australia, Feb. 27, 2019 -- Elixinol Global Limited (EXL or the Group) (ASX:EXL; OTCQX:ELLXF), a global company operating in the industrial hemp and emerging medicinal.

  • GlobeNewswire

    Elixinol Global Significantly Expands European Operations

    OTCQX: ELLXF), has expanded its EU operations with key personnel hires and offices in the Netherlands, Spain, and the United Kingdom. The appointments are accompanied by a new go-to-market strategy and key initiatives including the launch of new e-commerce capabilities, sales hubs, with 12 full-time sales and marketing employees, in the Netherlands, Spain, and the United Kingdom aimed at capturing the European cannabis market opportunity, which analysts expect will be worth more than $130 billion in annual sales by 2028 (in today’s dollars).

  • GlobeNewswire

    Streetwise Reports Examines Elixinol; Is It the Fastest Growing Hemp/CBD Producer?

    SAN FRANCISCO, Feb. 05, 2019 -- Fincom Investment Partners discusses Elixinol Global Ltd.'s (EXL:ASX; ELLXF:OTCQX)  Q4 earnings, and the hemp/CBD field. Company mentioned:.